Clinical features, management and prognosis of multifocal primary bone lymphoma: A retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)

British Journal of Haematology

Volumn 164, Issue 6, 2014, Pages 834-840

  Messina, Carlo ^a   Ferreri, Andrés J M ^a   Govi, Silvia ^a   Bruno Ventre, Marta ^a   Gracia Medina, Elías A ^b   Porter, David ^c   Radford, John ^d   Heo, Dae S ^e   Park, Hee Y ^f   Pro, Barbara ^g   Jayamohan, Jayasingham ^h   Visco, Carlo ⁱ   Scarfò, Lydia ^a   Zucca, Emanuele ^j   Gospodarowicz, Mary ^k   Christie, David ^l  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d CHRISTIE HOSPITAL   (United Kingdom)

^e Seoul National University Hospital   (South Korea)

^f Korea Cancer Centre Hospital   (South Korea)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h WESTMEAD HOSPITAL   (Australia)

ⁱ SAN BORTOLO HOSPITAL   (Italy)

^j ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^k PRINCESS MARGARET HOSPITAL   (Canada)

^l BOND UNIVERSITY   (Australia)

more..

Author keywords

Multifocal bone lymphoma; Osteolymphoma; Polyostotic lymphoma; Primary bone lymphoma

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CENTRAL NERVOUS SYSTEM TUMOR; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; MULTIFOCAL BONE DIFFUSE LARGE B CELL LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SKULL; SPINE;

MULTIFOCAL BONE LYMPHOMA; OSTEOLYMPHOMA; POLYOSTOTIC LYMPHOMA; PRIMARY BONE LYMPHOMA;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896733040     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12714     Document Type: Article

References (25)

1. Achemlal, L., Mikdame, M., Nouijai, A., Bezza, A. & El Maghraoui, A. (2006) Dramatical improvement of chemoresistant bone lymphoma with rituximab. Clinical Rheumatology, 25, 394-395.
2. Adams, H., Tzankov, A., d'Hondt, S., Jundt, G., Dirnhofer, S. & Went, P. (2008) Primary diffuse large B-cell lymphomas of the bone: Prognostic relevance of protein expression and clinical factors. Human Pathology, 39, 1323-1330.
3. Beal, K., Allen, L. & Yahalom, J. (2006) Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer, 106, 2652-2656.
4. Brousse, C., Baumelou, E. & Morel, P. (2000) Primary lymphoma of bone: a prospective study of 28 cases. Joint, Bone, Spine: Revue Du Rhumatisme, 67, 446-451.
5. Cai, L., Stauder, M.C., Zhang, Y.J., Poortmans, P., Li, Y.X., Constantinou, N., Thariat, J., Kadish, S.P., Nguyen, T.D., Kirova, Y.M., Ghadjar, P., Weber, D.C., Bertran, V.T., Ozsahin, M. & Mirimanoff, R.O. (2012) Early-stage primary bone lymphoma: a retrospective, multicenter rare cancer network (RCN) study. International Journal of Radiation Oncology, Biology, Physics, 83, 284-291.
6. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. & Tubiana, M. (1971) Report of the committee on hodgkin's disease staging classification. Cancer Research, 31, 1860-1861.
7. Christie, D.R., Barton, M.B., Bryant, G., Cheuk, R., Gebski, V., Hornsey, J., Lonergan, D., MacLeod, C., Pratt, G., Roos, D., Shannon, J., Thornton, D. & Wirth, A. (1999) Osteolymphoma (primary bone lymphoma): an australian review of 70 cases. australasian radiation oncology lymphoma group (AROLG). Australian and New Zealand Journal of Medicine, 29, 214-219.
8. Coiffier, B. (2005) State-of-the-art therapeutics: diffuse large B-cell lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 23, 6387-6393.
9. Durr, H.R., Muller, P.E., Hiller, E., Maier, M., Baur, A., Jansson, V. & Refior, H.J. (2002) Malignant lymphoma of bone. Archives of Orthopaedic and Trauma Surgery, 122, 10-16.
10. Fletcher, C.D. (2006) The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology, 48, 3-12.
11. Haioun, C., Besson, C., Lepage, E., Thieblemont, C., Simon, D., Rose, C., Tilly, H., Sonet, A., Lederlin, P., Attal, M., Briere, J. & Reyes, F. (2000) Incidence and risk factors of central nervous system relapse in histologically aggressive non-hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. groupe d'etudes des lymphomes de l'adulte. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO, 11, 685-690.
12. Heyning, F.H., Hogendoorn, P.C., Kramer, M.H., Hermans, J., Kluin-Nelemans, J.C., Noordijk, E.M. & Kluin, P.M. (1999) Primary non-hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK, 13, 2094-2098.
13. Horsman, J.M., Thomas, J., Hough, R. & Hancock, B.W. (2006) Primary bone lymphoma: a retrospective analysis. International Journal of Oncology, 28, 1571-1575.
14. Hsieh, P.P., Tseng, H.H., Chang, S.T., Fu, T.Y., Lu, C.L. & Chuang, S.S. (2006) Primary non-hodgkin's lymphoma of bone: a rare disorder with high frequency of T-cell phenotype in southern Taiwan. Leukemia & Lymphoma, 47, 65-70.
15. Jawad, M.U., Schneiderbauer, M.M., Min, E.S., Cheung, M.C., Koniaris, L.G. & Scully, S.P. (2010) Primary lymphoma of bone in adult patients. Cancer, 116, 871-879.
16. Jones, D., Kraus, M.D. & Dorfman, D.M. (1999) Lymphoma presenting as a solitary bone lesion. American Journal of Clinical Pathology, 111, 171-178.
17. Kaplan, E.L., Meier, P. (1958) Nonparametric estimation from incomplete observations. Biometrics, 53, 457-481.
18. Lee, H.Y., Kim, S.J., Kim, K., Ko, Y.H. & Kim, W.S. (2012) Bone involvement in patients with stage IV diffuse large B-cell lymphoma: does it have a prognostic value? Leukemia & Lymphoma, 53, 173-175.
19. Limb, D., Dreghorn, C., Murphy, J.K. & Mannion, R. (1994) Primary lymphoma of bone. International Orthopaedics, 18, 180-183.
20. Maruyama, D., Watanabe, T., Beppu, Y., Kobayashi, Y., Kim, S.W., Tanimoto, K., Makimoto, A., Kagami, Y., Terauchi, T., Matsuno, Y. & Tobinai, K. (2007) Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study. Japanese Journal of Clinical Oncology, 37, 216-223.
21. Miller, A.B., Hoogstraten, B., Staquet, M. & Winkler, A. (1981) Reporting results of cancer treatment. Cancer, 47, 207-214.
22. Pellegrini, C., Gandolfi, L., Quirini, F., Ruggieri, P., Stefoni, V., Derenzini, E., Broccoli, A., Argnani, L., Pileri, S., Mercuri, M., Baccarani, M. & Zinzani, P.L. (2011) Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients. Clinical Lymphoma, Myeloma & Leukemia, 11, 321-325.
23. Pettit, C.K., Zukerberg, L.R., Gray, M.H., Ferry, J.A., Rosenberg, A.E., Harmon, D.C. & Harris, N.L. (1990) Primary lymphoma of bone. a B-cell neoplasm with a high frequency of multilobated cells. The American Journal of Surgical Pathology, 14, 329-334.
24. Qureshi, A., Ali, A., Riaz, N. & Pervez, S. (2010) Primary non-hodgkin's lymphoma of bone: experience of a decade. Indian Journal of Pathology & Microbiology, 53, 267-270.
25. Ramadan, K.M., Shenkier, T., Sehn, L.H., Gascoyne, R.D. & Connors, J.M. (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia cancer agency. Annals of Oncology: Official Journal of the European Society for Medical Oncology/ESMO, 18, 129-135.